Sign in

MongoDB, Inc. MDB

Price 384.4 USD
as of 2026-09-05
51/100
No view
Quality25
Growth91
Balance-sheet strength81
Valuation17
Momentum63
Income50

Composite 51/100; the shares have moved about 69% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Valuation ranks 17/100 — a strong mark against it.

Case for

Growth ranks 91/100 — a strong point in its favour. Balance-sheet strength ranks 81/100 — a strong point in its favour. Momentum ranks 63/100 — a moderate point in its favour.

Case against

Valuation ranks 17/100 — a strong mark against it. Quality ranks 25/100 — a strong mark against it.

What the company does MongoDB provides a general-purpose, document-oriented database platform including Atlas (multi-cloud DBaaS), Enterprise Advanced (commercial server), and a free Community Server. Its stack is designed for developers building scalable, flexible applications.

Key financials Revenue grew 25.2% but margins remain negative: gross 72.0%, operating −3.6%, net −1.1%. ROE −1.0%, ROA −1.8%, ROCE −0.4%. Forward P/E 50.00; EV/EBITDA 804.95.

Stock health Quality score 23.4/100 (Poor), Growth 61.0, Strength 64.9, Momentum 56.9. Piotroski F-Score 6/9, Altman Z 19.76, Current ratio 4.95. RSI(14) 50.60.

Price vs fair value MongoDB trades at a PREMIUM of 70.00% versus our fair-value estimate of 97.76 and at a discount of 21.58% versus the 12-month target of 396.21. - Trading at 70.00% premium to fair-value estimate (Sideravia) - EV/EBITDA of 804.95 vs forward P/E of 50.00 (Valuation percentile 31.4/100) - Negative profitability despite 25.2% revenue growth (Key financials) - Strength and growth scores above 60, offset by poor quality (Sideravia pillar scores) - RSI near neutral at 50.60 (Momentum)

Looking forward Forward P/E of 50.00 implies high growth expectations. Analysts see 396.21 as a 12-month target, suggesting potential upside if execution improves and margins expand.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.